Helen Lin

1.1k total citations
33 papers, 807 citations indexed

About

Helen Lin is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Helen Lin has authored 33 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Cancer Research. Recurrent topics in Helen Lin's work include Alzheimer's disease research and treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Helen Lin is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Helen Lin collaborates with scholars based in United States, United Kingdom and Switzerland. Helen Lin's co-authors include James R. Connor, Bingjing Zheng, Lydia Lartigue, Benjamin Faustin, Yulia Kushnareva, Donald D. Newmeyer, David Julian McClements, David K. Ann, Charles G. Plopper and Don M. Carlson and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Cancer Research.

In The Last Decade

Helen Lin

33 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Lin United States 17 393 125 95 83 71 33 807
Takumi Nakamura Japan 16 226 0.6× 169 1.4× 85 0.9× 45 0.5× 57 0.8× 73 790
Katie R. Martin United States 19 478 1.2× 151 1.2× 101 1.1× 70 0.8× 122 1.7× 34 1.0k
Oleksandr Ekshyyan United States 15 444 1.1× 114 0.9× 49 0.5× 67 0.8× 178 2.5× 25 883
Elena Manara Italy 18 547 1.4× 108 0.9× 82 0.9× 47 0.6× 185 2.6× 65 1.1k
Sara A. Gibson United States 17 446 1.1× 77 0.6× 53 0.6× 77 0.9× 169 2.4× 20 1.0k
Danli Wu China 12 379 1.0× 64 0.5× 63 0.7× 65 0.8× 87 1.2× 21 788
Shoji Kawauchi Japan 15 389 1.0× 83 0.7× 90 0.9× 52 0.6× 85 1.2× 37 784
Giada Mondanelli Italy 21 417 1.1× 73 0.6× 79 0.8× 55 0.7× 153 2.2× 44 1.1k
Hong Qi United States 17 567 1.4× 166 1.3× 64 0.7× 45 0.5× 256 3.6× 27 1.5k
Rui Ji China 18 410 1.0× 62 0.5× 88 0.9× 71 0.9× 99 1.4× 49 893

Countries citing papers authored by Helen Lin

Since Specialization
Citations

This map shows the geographic impact of Helen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Lin more than expected).

Fields of papers citing papers by Helen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Lin. The network helps show where Helen Lin may publish in the future.

Co-authorship network of co-authors of Helen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Lin. A scholar is included among the top collaborators of Helen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Lin. Helen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mearns, Elizabeth S., et al.. (2024). Indirect Costs of Alzheimer’s Disease: Unpaid Caregiver Burden and Patient Productivity Loss. Value in Health. 28(4). 519–526. 1 indexed citations
2.
Brangman, Sharon A., Jacobo Mintzer, Michael Grundman, et al.. (2024). Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease. EClinicalMedicine. 73. 102693–102693. 5 indexed citations
3.
Kwon, Jennifer M., Kapil Arya, Nancy L. Kuntz, et al.. (2022). An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy. Annals of Clinical and Translational Neurology. 9(6). 810–818. 26 indexed citations
4.
Blum, Angela P., Jian Yin, Helen Lin, et al.. (2021). Stimuli Induced Uptake of Protein‐Like Peptide Brush Polymers. Chemistry - A European Journal. 28(5). e202103438–e202103438. 6 indexed citations
5.
Guthrie, Heather, Lawrence S. Honig, Helen Lin, et al.. (2020). Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks. Journal of Alzheimer s Disease. 76(3). 967–979. 41 indexed citations
6.
Yoshida, Kenta, Tobias Bittner, Susanne Ostrowitzki, et al.. (2020). Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer’s disease. Alzheimer s Research & Therapy. 12(1). 16–16. 37 indexed citations
7.
Zheng, Bingjing, Xiaoyun Zhang, Helen Lin, & David Julian McClements. (2019). Loading natural emulsions with nutraceuticals using the pH-driven method: formation & stability of curcumin-loaded soybean oil bodies. Food & Function. 10(9). 5473–5484. 36 indexed citations
8.
Asnaghi, Veronica, Helen Lin, Michael Rabbia, et al.. (2017). Long-Term Safety And Tolerability Of Escalating Doses Of Crenezumab In Patients With Mild-To-Moderate Alzheimer’s Disease (P6.083). Neurology. 88(16_supplement). 4 indexed citations
9.
Lin, Helen, et al.. (2011). An overview of the rare parotid gland cancer. Head & Neck Oncology. 3(1). 40–40. 54 indexed citations
10.
Rezania, Kourosh, et al.. (2011). Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leukemia & lymphoma. 53(3). 371–380. 17 indexed citations
11.
Lowery, Jason, Tomasz Szul, J. Seetharaman, et al.. (2011). Novel C-terminal Motif within Sec7 Domain of Guanine Nucleotide Exchange Factors Regulates ADP-ribosylation Factor (ARF) Binding and Activation. Journal of Biological Chemistry. 286(42). 36898–36906. 16 indexed citations
12.
Kafasla, Panagiota, Helen Lin, Stephen Curry, & Richard J. Jackson. (2011). Activation of picornaviral IRESs by PTB shows differential dependence on each PTB RNA-binding domain. RNA. 17(6). 1120–1131. 30 indexed citations
13.
Jeng, Cherng‐Jye, et al.. (2010). The Effect of HPV Infection on a Couple's Relationship: A Qualitative Study in Taiwan. Taiwanese Journal of Obstetrics and Gynecology. 49(4). 407–412. 15 indexed citations
14.
Lartigue, Lydia, et al.. (2009). Caspase-independent Mitochondrial Cell Death Results from Loss of Respiration, Not Cytotoxic Protein Release. Molecular Biology of the Cell. 20(23). 4871–4884. 104 indexed citations
15.
Pinthus, Jehonathan H., et al.. (2007). Androgen‐dependent regulation of medium and long chain fatty acids uptake in prostate cancer. The Prostate. 67(12). 1330–1338. 23 indexed citations
16.
Zhou, Beiyun, David K. Ann, Xian Li, et al.. (2006). Hypertonic induction of aquaporin-5: novel role of hypoxia-inducible factor-1α. American Journal of Physiology-Cell Physiology. 292(4). C1280–C1290. 38 indexed citations
17.
Lin, Helen, et al.. (2003). Multilineage Potential of Homozygous Stem Cells Derived from Metaphase II Oocytes. Stem Cells. 21(2). 152–161. 55 indexed citations
18.
Lin, Helen, Brian S. Snyder, & James R. Connor. (1990). Transferrin expression in myelinated and non-myelinated peripheral nerves. Brain Research. 526(2). 217–220. 18 indexed citations
19.
Lin, Helen, Don M. Carlson, Judith A. St. George, Charles G. Plopper, & Reen Wu. (1989). An ELISA Method for the Quantitation of Tracheal Mucins from Human and Nonhuman Primates. American Journal of Respiratory Cell and Molecular Biology. 1(1). 41–48. 73 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026